Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.

Carethers JM.

Therap Adv Gastroenterol. 2008 Jul;1(1):33-42. doi: 10.1177/1756283X08093607.

2.

Integration of novel agents in the treatment of colorectal cancer.

Iqbal S, Lenz HJ.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. Review.

PMID:
15309512
3.

Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009).

Zinser-Sierra JW, Rodríguez-Ramírez S, Villalobos-Valencia R, Ramírez-Márquez M.

Drugs R D. 2011;11(2):101-11. doi: 10.2165/11590440-000000000-00000. Review.

4.

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.

Tappenden P, Jones R, Paisley S, Carroll C.

Health Technol Assess. 2007 Mar;11(12):1-128, iii-iv. Review.

5.

Advances in chemotherapy against advanced or metastatic colorectal cancer.

Omura K.

Digestion. 2008;77 Suppl 1:13-22. doi: 10.1159/000111483. Epub 2008 Jan 18. Review.

6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
7.

New oxaliplatin-based combinations in the treatment of colorectal cancer.

Cassidy J, Hochster H.

Colorectal Dis. 2003 Nov;5 Suppl 3:1-9. Review.

PMID:
23573555
8.

Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.

Venook AP.

J Natl Compr Canc Netw. 2004 Sep;2 Suppl 2:S74-84. Review.

PMID:
19780248
10.

Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R; Head and Neck Cancer Disease Site Group.

Curr Oncol. 2010 Jun;17(3):37-48.

11.

An update on treatment advances for the first-line therapy of metastatic colorectal cancer.

Lee JJ, Chu E.

Cancer J. 2007 Sep-Oct;13(5):276-81. Review.

PMID:
17921724
12.

Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer.

Lee JJ, Chu E.

Clin Colorectal Cancer. 2007 Dec;7 Suppl 1:S16-20. Review.

PMID:
18361802
13.

Systemic treatment of colorectal cancer.

Tebbutt NC, Cattell E, Midgley R, Cunningham D, Kerr D.

Eur J Cancer. 2002 May;38(7):1000-15. Review.

PMID:
11978525
15.

Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.

Jean GW, Shah SR.

Pharmacotherapy. 2008 Jun;28(6):742-54. doi: 10.1592/phco.28.6.742. Review.

PMID:
18503402
16.

[Treatment of advanced and/or metastatic colorectal cancer with bevacizumab in combination with oxaliplatin-based chemotherapy (Folfox7 regimen)].

Oukkal M, Djilat K, Hadjam RM, Mahgoun M, Bentabak K, Graba A, Smail N, Kaci NA, Ahmed RB, Bouzid K.

Bull Cancer. 2010 Apr;97(4):469-74. doi: 10.1684/bdc.2010.1088. French.

17.
18.

New developments in systemic chemotherapy in advanced colorectal cancer.

Cats A.

Scand J Gastroenterol Suppl. 2003;(239):78-86. Review.

PMID:
14743888
20.

Current treatments and future perspectives in colorectal and gastric cancer.

Wilke HJ, Van Cutsem E.

Ann Oncol. 2003;14 Suppl 2:ii49-55. Review.

PMID:
12810459

Supplemental Content

Support Center